









Markets
/
Stocks
/
nasdaq-acb
/

Aurora Cannabis Inc

ACB

3.115USD

-0.225-6.74%

Market hours （ET）Quotes delayed by 15 min

412.48KMarket Cap

LossP/E TTM



Aurora Cannabis Inc

3.115

-0.225-6.74%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Aurora Cannabis Inc

Currency: USD Updated: 2026-03-27

Key Insights

Aurora Cannabis Inc's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 93 out of 157 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 32.00.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Aurora Cannabis Inc's Score

Industry at a Glance

Industry Ranking

93 / 157

Overall Ranking

238 / 4542

Industry

Pharmaceuticals

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

Aurora Cannabis Inc Highlights

StrengthsRisks

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally. The Company’s segments include Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, IndiMed and CraftPlant. The Company also holds a 50.1% controlling interest in Bevo Farms Ltd., a supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 92.27% year-on-year.

Turnaround to Profit

The company's performance has turned profitable, with the latest annual net income of USD .

Fairly Valued

The company’s latest PE is -2.93, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 11.95M shares, decreasing 0.03% quarter-over-quarter.

Analyst Rating

Based on 4 analysts

Buy

Current Rating

32.000

Target Price

+443.29%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-03-27

The current financial score of Aurora Cannabis Inc is 6.23, ranking 143 out of 157 in the Pharmaceuticals industry. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 68.94M, representing a year-over-year increase of 11.83%, while its net profit experienced a year-over-year increase of 93.98%.

Score

Industry at a Glance

Previous score

6.23

Change



Financials

6.07

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

2.54

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

10.00

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

5.32

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.23

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Aurora Cannabis Inc's Company Valuation

Currency: USD Updated: 2026-03-27

The current valuation score of Aurora Cannabis Inc is 8.98, ranking 1 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is -2.93, which is -7399.01% below the recent high of 213.93 and -781.35% above the recent low of -25.83.

Score

Industry at a Glance

Previous score

8.98

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 93/157

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-03-27

The current earnings forecast score of Aurora Cannabis Inc is 7.20, ranking 108 out of 157 in the Pharmaceuticals industry. The average price target is 32.00, with a high of 32.00 and a low of 32.00.

Score

Industry at a Glance

Previous score

7.20

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 4 analysts

Buy

Current Rating

32.000

Target Price

+443.29%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

174

Total

Median

Average

Company name

Ratings

Analysts

Aurora Cannabis Inc

ACB

Biogen Inc

BIIB

Amgen Inc

AMGN

Eli Lilly and Co

LLY

Vertex Pharmaceuticals Inc

VRTX

Gilead Sciences Inc

GILD

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-03-27

The current price momentum score of Aurora Cannabis Inc is 6.16, ranking 128 out of 157 in the Pharmaceuticals industry. Currently, the stock price is trading between the resistance level at 3.58 and the support level at 3.01, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.58

Change

-0.42

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(5)

Neutral(1)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.011

Sell

RSI(14)

36.204

Neutral

STOCH(KDJ)(9,3,3)

19.754

Sell

ATR(14)

0.127

Low Volatility

CCI(14)

-135.259

Sell

Williams %R

98.543

Oversold

TRIX(12,20)

-0.459

Sell

StochRSI(14)

0.000

Sell

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

3.318

Sell

MA10

3.367

Sell

MA20

3.454

Sell

MA50

3.714

Sell

MA100

4.126

Sell

MA200

4.563

Sell

Institutional Confidence

Currency: USD Updated: 2026-03-27

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Tidal Investments LLC

1.34M

-11.11%

Two Sigma Investments, LP

1.40M

+2178.01%

Goldman Sachs & Company, Inc.

1.71M

+21.35%

Renaissance Technologies LLC

Star Investors

786.05K

+14.66%

Global X Investments Canada Inc.

479.13K

Citadel Advisors LLC

477.54K

+115.55%

Morgan Stanley Canada Limited

199.49K

-10.63%

Millennium Management LLC

391.78K

+563.68%

AdvisorShares Investments, LLC

190.38K

+277.89%

Jane Street Capital, L.L.C.

119.61K

+86.59%

Risk Assessment

Currency: USD Updated: 2026-03-27

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Pharmaceuticals domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Aurora Cannabis Inc is 4.29, ranking 88 out of 157 in the Pharmaceuticals industry. The company's beta value is 1.30. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.